TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill July 6, 1979
TCL Archive Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds January 29, 2010
TCL Archive In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million August 19, 1983
